TrialEBioMedicine2022

Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial.

Johannes Levin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.